About Revere Pharmaceuticals
Revere Pharmaceuticals is a private company based in Arlington, Massachusetts. It has reported $6,133,645 raised in three offerings on Form D since June 2019. Its chief executive is Ian Silverman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | Jun 12, 2023 | $1,622,604of $3.5M target | 22 | $73,755 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 27, 2021 | Sep 1, 2021 | $1,056,199of $1.9M target | 30 | $35,207 | EquityRule 506(b) | Form D ↗ |
| Jun 11, 2019 | Jun 21, 2019amended Jan 12, 2021 | $3,454,842fully sold | 61 | $56,637 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, three offerings | $6,133,645 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Revere Pharmaceuticals's Form D filed Jun 12, 2023.
KP
Kollol Pal
Director
ML
Marc Lippman
Director
IS
Ian Silverman
President and Chief Executive Officer, director
JL
Jedd Levine
Executive officer and director